TRPC6 Inhibitor BI 764198 in Focal Segmental Glomerulosclerosis: Phase 2 Study Design

• Howard Trachtman,
• Matthias Kretzler,
• Hailey E. Desmond,
• Wansuk Choi,
• Raymond C. Manuel,
• Nima Soleymanlou

Affiliations

Howard Trachtman

Division of Nephrology, University of Michigan, Ann Arbor, Michigan, USA

Matthias Kretzler

Division of Nephrology, University of Michigan, Ann Arbor, Michigan, USA

Hailey E. Desmond

Division of Nephrology, University of Michigan, Ann Arbor, Michigan, USA

Wansuk Choi

Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA

Raymond C. Manuel

Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA

Nima Soleymanlou

Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA; Correspondence: Nima Soleymanlou, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, USA.